Edwards Finds Transcatheter Valve Adoption In U.S. Slower Than Expected
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences is lowering its revenue expectations for 2013 based on adoption rates so far of its transcatheter aortic valve implant technology.